Dr. Lok is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Education & Training
- Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine, 1989 - 1991
- University of Hong Kong Faculty of MedicineClass of 1977
Certifications & Licensure
- MI State Medical License 1998 - 2027
- LA State Medical License 1994 - 2005
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment Start of enrollment: 2000 Jun 01
- Hepatitis B Research Network Adult Cohort Study Start of enrollment: 2010 Dec 01
- Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B Start of enrollment: 2012 May 01
- Join now to see all
Publications & Presentations
PubMed
- 37 citationsLean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Comorbid DiseasesEthan M. Weinberg, Huy N. Trinh, Roberto J. Firpi, Kalyan Ram Bhamidimarri, Samuel Klein
Clinical Gastroenterology and Hepatology. 2021-05-01 - 67 citationsOutcomes of patients with chest tube insertion for hepatic hydrothoraxEric S. Orman, Anna S. F. Lok
Hepatology International. 2009-08-11 - 188 citationsEffectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis.Amit G. Singal, Hari S. Conjeevaram, Michael L. Volk, Sherry Fu, Robert J. Fontana
Cancer Epidemiology, Biomarkers & Prevention. 2012-02-28
Journal Articles
- Awareness and Knowledge of Nonalcoholic Fatty Liver Disease Among Office Employees in Beijing, ChinaAnna S Lok, Stephanie Chen, Samantha Chao, Digestive Diseases and Sciences
- Frailty, Psychoactive Medications, and Cognitive Dysfunction Are Associated with Poor Patient‐Reported Outcomes in CirrhosisElliot B Tapper, Neehar D Parikh, Anna S Lok, Hepatology
Other
- Spike in Hep C Infections Mutes Thrill of Recent CureAnna Lok, MD, U-M Health System
https://www.doximity.com/articles/6ec15d6f-c828-4ef0-ab64-dbb58284003e
UpToDate, Wolters Kluwer Health - 2013-02-07 - Clinical significance and molecular characteristics of common hepatitis B virus variantsLok AS, Chu C
http://www.uptodate.com/contents/clinical-significance-and-molecular-characteristics-of-common-hepat
UpToDate, Wolters Kluwer Health - 2013-02-05 - Hepatitis D virus reinfection following liver transplantationLok AS
http://www.uptodate.com/contents/hepatitis-d-virus-reinfection-following-liver-transplantation
UpToDate, Wolters Kluwer Health - 2013-01-07 - Join now to see all
Authored Content
- Spike in Hep C Infections Mutes Thrill of Recent CureAugust 2018
Press Mentions
- No Racial Disparities Observed in Chronic HBV Treatment Rates Among Eligible PatientsApril 12th, 2023
- Five Faculty Members with Diverse Backgrounds Elected to National Academy of MedicineOctober 17th, 2022
- Then and Now: Demographics of the AGAJune 1st, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: